MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems The product is a medical device (chemistry reagent) and is intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems. The kit is provided as a ready to use liquid material consisting in two components: Reagent 1 and Reagent 2. According to the catalogue number, the kit is composed of three vials of 48 ml for Reagent 1 and three vials of 18 ml for Reagent 2 in the configuration 8L24-31. The configuration 8L24-41 consists in ten vials of 90 ml for Reagent 1 and ten vials of 34 ml for Reagent 2
Published August 9, 2017 · Recall initiated: May 22, 2017
Summary
FDA records medical device Class II recall Z-2867-2017, published August 9, 2017 and initiated May 22, 2017. Recalling firm: Sentinel CH SPA; Status: Terminated; Reported quantity: 2356 kits Worldwide; US 206 kits; Lot: Catalog Number 8L24-31: Lot Numbers: 60335Y600, 60382Y600 (Exp. Date 2018-02-28); Catalog Number 8L24-41: Lot Number: 60334Y600, (Exp. Date 2018-02-28). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sentinel CH SPA
- Distributor
- Nationwide Distribution
- Lot
- Catalog Number 8L24-31: Lot Numbers: 60335Y600, 60382Y600 (Exp. Date 2018-02-28); Catalog Number 8L24-41: Lot Number: 60334Y600, (Exp. Date 2018-02-28)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Italy
Related recalls
- FDAGlipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack perAugust 16, 2017
- FDATomcat Instrument, REF ASY-07379, Hologic Incorporated, automated laboratory sample processing instrument.August 9, 2017
- FDAROSA Brain, 3.0.0 The device is intended for the spatial positioning and orientation of instrument holders orAugust 9, 2017
- FDAInflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test forAugust 9, 2017
- FDANon-Locking screws in the following lengths: (a) NEO(R) 0.27 - 10 mm, REF W27 ST010 (b) NEO(R) 0.27 - 12 mm,August 9, 2017
- FDAStroke Fast Pack(TM) Trevo XP ProVue Retriever 4 x 30, Trevo Pro 18 Microcatheter, AXS Catalyst 060x132CM -August 9, 2017
Questions about this recall
Was MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems The product is a medical device (chemistry reagent) and is intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems. The kit is provided as a ready to use liquid material consisting in two components: Reagent 1 and Reagent 2. According to the catalogue number, the kit is composed of three vials of 48 ml for Reagent 1 and three vials of 18 ml for Reagent 2 in the configuration 8L24-31. The configuration 8L24-41 consists in ten vials of 90 ml for Reagent 1 and ten vials of 34 ml for Reagent 2 recalled?
Yes. FDA published recall Z-2867-2017 on August 9, 2017. Reported hazard: Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration.
What should I do if I have this product?
Voluntary: Firm initiated · Letter